Filing identity and reporting period
Important mismatch: The supplied filing is a Form 10-K for General Sales and Leasing, Inc. (formerly General Aircraft, Inc.), not Xenetic Biosciences, Inc. It covers the fiscal year ended August 31, 2013—not 2012 Q4. The filing describes a proposed acquisition of Xenetic Biosciences plc, which remained conditional.
Business context
During the fiscal year, the company’s principal operating asset was one Robinson R44 helicopter rented in the Las Vegas area. A revised lease with Elite Aviation, effective November 1, 2012, shifted maintenance, insurance, hangar, fuel, and oil costs to the lessee in exchange for a stated rate of $185 per Hobbs hour. The helicopter reached its mandatory overhaul interval in April 2013 and was taken out of service. The company also formed an online advertising subsidiary, Shift It Media Co.; it abandoned a separate optical-touch technology opportunity.
Financial performance and position
| Metric | FY ended Aug. 31, 2013 | FY ended Aug. 31, 2012 |
|---|---|---|
| Revenue, net of cost of sales | $96,900 | $112,786 |
| Operating expenses | $162,457 | $229,447 |
| Operating loss | $(65,557) | $(116,661) |
| Net loss | $(89,172) | $(129,673) |
| Basic and diluted loss per share | $(0.00) | $(0.01) |
| Net cash from (used in) operating activities | $280,609 | $(12,995) |
| Net cash used in investing activities | $(259,392) | $0 |
| Cash at year-end | $53,222 | $32,005 |
Revenue declined about 14%; the net loss narrowed by about 31%, mainly alongside lower operating expenses. Operating cash flow was positive despite the net loss, with the cash flow statement showing substantial cash effects from changes in receivables and payables. The filing does not provide a clear gross-margin figure.
At August 31, 2013, total assets were $486,809, including net property and equipment of $413,866. Current liabilities were $456,076 and current assets were $72,943, producing a $383,133 working-capital deficit. Total liabilities were $668,889 and stockholders’ deficit was $182,080.
Aircraft purchase financing had $212,813 principal outstanding, bore 6% interest, and matured August 11, 2016. A separate North Star facility allowed up to $220,000 for the overhaul at 9.5% interest; $160,000 was drawn after year-end on October 4, 2013. The filing says the overhaul bill was included in accounts payable at year-end. No off-balance-sheet arrangements were reported.
Material changes, outlook, and risks
- The new lease arrangement reduced the company’s responsibility for operating costs. The company reported $88,260 of helicopter rental revenue under its Elite agreement during FY2013.
- The helicopter overhaul was expected to cost $200,000–$220,000 and be completed before year-end 2013; the filing elsewhere anticipates completion in early December. While the helicopter was out of service, it generated no rental revenue. Management expected to negotiate a replacement lease at $185–$200 per hour with a 40-hour monthly minimum; this was not presented as a completed agreement.
- The auditor issued an unqualified opinion on the financial statements but highlighted substantial doubt about the company’s ability to continue as a going concern. Management reported no formal plan, relying on possible equity financing or related-party advances, with no assurance funds would be available.
- Management found disclosure controls and internal control over financial reporting ineffective, citing inadequate segregation of duties and insufficient written accounting and reporting procedures. The company had not remediated these weaknesses; improvements depended partly on obtaining financing.
- On November 12, 2013, the company agreed to a proposed all-share acquisition of Xenetic Biosciences plc through a UK scheme of arrangement, subject to shareholder, court, and other approvals. The proposed exchange was 56 company shares for every 175 Xenetic plc shares, with approximately 130.5 million shares expected to be issued before a planned 10-for-1 reverse split. The filing says those shares, after the split and cancellation of Oxbridge’s shares, would represent over 97% of shares outstanding.
- Under a related “Hive Out” agreement, Oxbridge Technology Partners would acquire the aircraft and advertising subsidiaries and receive $430,000 cash in exchange for cancellation of its 100 million shares, subject to the scheme becoming effective. The filing’s stated expected effective date is “January 23, 2013,” which is inconsistent with the November 2013 transaction timetable and is likely erroneous; the correct date is not clear from this filing text.
- Other risks include limited OTC trading and penny-stock restrictions, dependence on financing, competition, regulatory or economic changes, and the possibility that the proposed acquisition would not be completed.
Most important facts for investors to verify
- Confirm the issuer and reporting period: this is General Sales and Leasing’s FY2013 10-K, not a Xenetic Biosciences 10-K for 2012 Q4.
- Check subsequent filings for completion or failure of the Xenetic plc scheme, the Hive Out, share issuance, reverse split, and any corrected effective-date timetable.
- Verify the helicopter overhaul’s final cost, completion and return-to-service date, facility draws and repayment terms, and whether a new lease was executed.
- Assess liquidity and going-concern developments, including the substantial working-capital deficit, overdue or accrued liabilities, and availability of further funding.
- Review remediation of the reported material weaknesses in disclosure controls and internal control over financial reporting.